|
NET1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.403970E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.420100E-04 |
| Normal-vs-Stage2 |
3.560899999977E-06 |
| Normal-vs-Stage3 |
5.03620001257588E-09 |
| Normal-vs-Stage4 |
4.7165000016669E-08 |
| Stage1-vs-Stage2 |
4.764200E-02 |
| Stage1-vs-Stage3 |
2.123400E-03 |
| Stage1-vs-Stage4 |
1.962170E-03 |
| Stage2-vs-Stage3 |
6.245800E-01 |
| Stage2-vs-Stage4 |
5.077600E-01 |
| Stage3-vs-Stage4 |
8.279200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.78599999995011E-06 |
| Normal-vs-AfricanAmerican |
8.13310000000733E-05 |
| Normal-vs-Asian |
6.421200E-03 |
| Caucasian-vs-AfricanAmerican |
7.553400E-01 |
| Caucasian-vs-Asian |
5.567800E-01 |
| AfricanAmerican-vs-Asian |
8.760800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.20869999999485E-05 |
| Normal-vs-Female |
3.055200E-01 |
| Male-vs-Female |
3.684000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.140500E-03 |
| Normal-vs-Extreme_Weight |
4.35990000002828E-06 |
| Normal-vs-Obese |
5.7664999999929E-05 |
| Normal-vs-Extreme_Obese |
1.231530E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.211200E-01 |
| Normal_Weight-vs-Obese |
7.056400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.691800E-01 |
| Extreme_Weight-vs-Obese |
7.553800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.354200E-01 |
| Obese-vs-Extreme_Obese |
2.744200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.961370E-04 |
| Normal-vs-Age(41-60Yrs) |
2.738500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.96779999967123E-07 |
| Normal-vs-Age(81-100Yrs) |
2.184400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.539790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.947200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.073600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.303700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.883400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.021600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.816700E-04 |
| Normal-VS-Type2 PRCC |
1.00010000281259E-09 |
| Normal-VS-KIRP CIMP |
8.84260442646223E-11 |
| Normal-VS-Unclassified PRCC |
1.65669999996343E-06 |
| Type1 PRCC-VS-Type2 PRCC |
8.966400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.51959999975071E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
2.520100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.762700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.283600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.715700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.34459999970404E-07 |
| Normal-vs-N1 |
6.719500E-03 |
| Normal-vs-N2 |
6.701000E-03 |
| N0-vs-N1 |
8.939400E-01 |
| N0-vs-N2 |
7.035600E-01 |
| N1-vs-N2 |
7.870400E-01 |
|
|
